ACCOUNTS - Final Accounts preparation



	BRE-BMR CITP (Cambridge) Limited













	Financial statements

	For the year ended 31 December 2025

	Registered number: 04201938


BRE-BMR CITP (Cambridge) Limited - Registered number:04201938

Statement of financial position

As at 31 December 2025

		2025		2024
Note		£		£


Current assets
Debtors	4	123,247,743		123,270,467
Bank and cash balances		29		41
		123,247,772		123,270,508
Creditors: amounts falling due within one year	5	(42,274,642)		(42,274,917)
Net current assets			80,973,130		80,995,591
Total assets less current liabilities			80,973,130		80,995,591

Net assets			80,973,130		80,995,591

Capital and reserves
Called up share capital	1	1
Capital contributions	1,082,824	1,082,824
Profit and loss account	79,890,305	79,912,766
	80,973,130	80,995,591

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by:

Orestis Tzortzoglou

Director

Date: 17 September 2026

The notes on pages 2 to 4 form part of these financial statements.

Page 1


BRE-BMR CITP (Cambridge) Limited

Notes to the financial statements

For the year ended 31 December 2025

1.	General information

BRE-BMR CITP (Cambridge) Limited is a private company limited by shares and incorporated in England and Wales. The registered office of the company is C/O Buzzacott LLP, 130 Wood Street, London, EC2V 6DL and the principal place of business is The McClintock Building, Granta Park, Great Abington, Cambridge, CB21 6GP. The registered number is 04201938.

2.Accounting policies

2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

2.2

Going concern

The directors have received assurance from BRE-BMR CITP Holdco Limited that it will provide continuing financial support to the company sufficient to allow it to continue trading for the foreseeable future. On this basis, the directors consider it appropriate to prepare the financial statements on a going concern basis.

However, should this support be withdrawn or future funding not be available, the going concern basis used in preparing the company's financial statements may be invalid and adjustments would have to be made to reduce the value of the assets to their realisable amount and to provide for any further liabilities that might arise. The financial statements do not include any adjustment to the company's assets or liabilities that might be necessary should the going concern basis not continue to be appropriate.

2.3

Foreign currency translation

Functional and presentation currency

The company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

2.4

Interest income

Interest income is recognised in profit or loss using the effective interest method.

Page 2


BRE-BMR CITP (Cambridge) Limited

Notes to the financial statements

For the year ended 31 December 2025

2.Accounting policies (continued)

2.5

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates income.

2.6

Debtors

Short-term debtors are measured at transaction price, less any impairment.

2.7

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Employees

The average monthly number of employees during the year was 0 (2024 - 0).

The directors are not considered to be employees of the company as they are remunerated through another group company.

Debtors

					2025	2024
					£	£


Amounts owed by group undertakings	123,242,565	123,265,087
Other debtors	5,178	5,380
	123,247,743	123,270,467

5.	Creditors: amounts falling due within one year
		2025	2024
		£	£

Amounts owed to group undertakings	42,117,320	42,117,320
Accruals and deferred income	157,322	157,597
	42,274,642	42,274,917

Page 3


BRE-BMR CITP (Cambridge) Limited

Notes to the financial statements

For the year ended 31 December 2025

6.	Inclusion in consolidated financial statements

BioMed Realty, L.P. is the parent company of the smallest group of which the company is a member
and for which group financial statements are prepared. The registered office of BioMed Realty, L.P. is
7 St. Paul Street, Suite 820, Baltimore MD, 21202, United States of America.

7.	Auditor's information

The auditor's report on the financial statements for the year ended 31 December 2025 was unqualified.

The audit report was signed on 18 September 2026 by Thomas Allison (Senior statutory auditor) on behalf of Buzzacott Audit LLP.

Page 4